A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
Abstract The current COVID-19 pandemic has heavily burdened the global public health system and may keep simmering for years. The frequent emergence of immune escape variants have spurred the search for prophylactic vaccines and therapeutic antibodies that confer broad protection against SARS-CoV-2...
Enregistré dans:
Auteurs principaux: | Zhenlin Yang, Yulu Wang, Yujia Jin, Yuanfei Zhu, Yanling Wu, Cheng Li, Yu Kong, Wenping Song, Xiaolong Tian, Wuqiang Zhan, Ailing Huang, Shanshan Zhou, Shuai Xia, Xiaoxu Tian, Chao Peng, Cuicui Chen, Yibing Shi, Gaowei Hu, Shujuan Du, Yuyan Wang, Youhua Xie, Shibo Jiang, Lu Lu, Lei Sun, Yuanlin Song, Tianlei Ying |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/06f49be0a9fe4fccae87b81c545ff0ab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The glycosylation in SARS-CoV-2 and its receptor ACE2
par: Yanqiu Gong, et autres
Publié: (2021) -
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
par: Ivan T. Lee, et autres
Publié: (2020) -
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
par: Jiwan Ge, et autres
Publié: (2021) -
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
par: Changhai Lei, et autres
Publié: (2020) -
High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
par: Chao Liu, et autres
Publié: (2021)